C ardiovascular disease (CVD) is strikingly increased in women with obesity, the metabolic syndrome, and diabetes mellitus, 1,2 all of which are promoted by increased consumption of a Western diet (WD) high in both fat and sugar. 2 For example, the Framingham Heart Study showed that left ventricular (LV) mass and wall thickness is proportionately greater in women than in men with worsening glucose intolerance.
C ardiovascular disease (CVD) is strikingly increased in women with obesity, the metabolic syndrome, and diabetes mellitus, 1,2 all of which are promoted by increased consumption of a Western diet (WD) high in both fat and sugar. 2 For example, the Framingham Heart Study showed that left ventricular (LV) mass and wall thickness is proportionately greater in women than in men with worsening glucose intolerance. 3 Emerging data also indicate that aldosterone levels are higher in overweight and hypertensive women and that the elevated plasma aldosterone is positively associated with markers of concentric cardiac remodeling like LV wall thickness in females but not in males. [3] [4] [5] [6] Mineralocorticoid excess and enhanced macrophage, vascular, and cardiac mineralocorticoid receptor (MR) signaling have been associated with increased fibrosis, inflammation, oxidative stress, and maladaptive cardiac remodeling. [7] [8] [9] [10] [11] [12] [13] [14] An early functional manifestation of this maladaptive remodeling and fibrosis is diastolic dysfunction characterized by impaired diastolic relaxation with preserved systolic function. 3, 4 In this regard, there is increasing evidence that obese and diabetic women are more likely to develop diastolic dysfunction than their male counterparts. 3, [14] [15] [16] [17] [18] Furthermore, diastolic dysfunction is often associated with systemic and cardiovascular fibrosis, LV hypertrophy, and insulin resistance, suggesting that there is an imbalance between December 2015 profibrotic, inflammatory, growth, and insulin metabolic signaling pathways. 2, [19] [20] [21] [22] Endothelial dysfunction often occurs in conditions of obesity and insulin resistance. 2, [23] [24] [25] In insulin-resistant states, there is decreased cardiovascular insulin metabolic signaling, resulting in attenuated endothelial nitric oxide synthase (eNOS) activation, and an increased profibrotic environment. [19] [20] [21] [22] Furthermore, increased generation of reactive oxygen species plays a role in impaired vascular insulin metabolic signaling by increasing redox sensitive serine (Ser) kinase activation/phosphorylation (p), such as S6K-1. 18, 21, [24] [25] [26] These activated Ser kinases decrease insulin receptor-1 (IRS-1) tyrosine (p) and engagement with phosphoinositol 3-kinase (PI3-K), with a resultant decrease in protein kinase B (Akt)-mediated (p)/activation of eNOS. 19, 22, [25] [26] [27] There is also mounting evidence that elevated plasma aldosterone and enhanced systemic and cardiovascular MR signaling contributes to systemic and cardiovascular fibrosis, insulin resistance, 4, 19, 28 and associated endothelial dysfunction. 21, 28 Endothelial cells (ECs) express MRs, as well as the 11β-hydroxysteroid dehydrogenase enzyme, which limit glucocorticoid signaling through these receptors. [29] [30] [31] Increased MR expression and signaling in ECs of rodent models has been shown to increase generation of vascular reactive oxygen species and reduce bioavailable nitric oxide (NO) and thus impair endothelial-mediated vascular relaxation. 29, 30 Utilization of cell-specific MR null mice has identified a role for cardiomyocyte, macrophage, and endothelial cell mineralocorticoid receptors (ECMRs) in aldosterone/ deoxycorticosterone acetate (DOCA) and salt-induced oxidative stress and inflammation-mediated cardiac tissue fibrosis, remodeling, and dysfunction in male mice. [8] [9] [10] [11] [12] [13] In each of these cell-specific null models, there was protection afforded by the cell-specific MR deletion. However, those EC studies were conducted with Tie2-promoter driving expression of Cre-recombinase in ECs and other myeloid lineage cells. Given the importance of macrophage MRs in promoting cardiac remodeling, [8] [9] [10] [11] the protection in this MR null model may have reflected, in part, the deletion of MRs from macrophages and other myeloid cells. The choice to study females was predicted on the fact that all previous studies were done in males and our previous observations that females are more prone than males to develop elevated plasma aldosterone levels, cardiac fibrosis, and diastolic dysfunction in the setting of WD consumption and the development of insulin resistance. 4, 19, 32 
Materials and Methods

Animals and Treatments
ECMR knockout (KO; ECMR −/− ) mice were kindly provided by Drs Jaffe and Mueller from Tufts University Medical Center who also contributed to the design of this investigation. 33 In these mice, exons 5 and 6 of the MR gene are flanked by loxP sites via homologous recombination (MR f/f ), as previously described. 33 
Results
Effects of ECMR KO on Body Composition and Insulin Sensitivity of Mice Fed a WD
Twenty-week-old ECMR +/+ and ECMR −/− female mice fed control diet had similar whole body fat mass, body weight, and insulin sensitivity as assessed by homeostasis model assessment-estimated insulin resistance (Table) . As expected, consumption of a WD for 16 weeks by ECMR +/+ mice induced an 83% increase in whole body fat mass, a >6 times increase in body perireproductive fat mass and insulin resistance compared with control diet-fed mice (P<0.05; Table) . There was no significant difference in WD-induced changes in body composition or insulin sensitivity in ECMR −/− versus ECMR +/+ mice. Of note, there were also no significant differences in lean body weight or mean arterial pressures between any of the groups (Table) .
ECMR −/− Prevents Development of Diastolic Dysfunction
Consistent with our previous report, 4 WD induced LV diastolic dysfunction and stiffness in ECMR +/+ female mice (Figure 1 ). After 16 weeks of WD feeding, ECMR +/+ mice exhibited prolonged diastolic relaxation time in concert with slower initial and peak filling rates as assessed by cine-magnetic resonance imaging ( Figure 1A-1D ). These impairments were consistent with abnormal echocardiographic-derived diastolic parameters, including impaired septal annular wall motion, which was indicated by a reduction in the tissue Doppler-derived E′/A′ ratio, an abnormal myocardial performance index and a prolonged period of isovolumic relaxation relative to control ( Figure 1E-1G ). Furthermore, ECMR +/+ mice also exhibited an increase in cardiomyocyte stiffness assessed in vitro as determined by atomic force microscopy ( Figure 1H ). These abnormalities were not observed in WD-fed ECMR −/− mice, indicating that the absence of ECMR affords protection from the deleterious effects of WD that promote diastolic dysfunction and stiffness ( Figure 1 ). To determine the role of ECMR in structural parameters involved in impairments in cardiac diastolic relaxation, we evaluated myocardial fibrosis by Verhoeff-van Gieson staining for total collagen and immunostaining for collagen 1, connective TGF, and fibronectin in ECMR +/+ and ECMR −/− mice fed a WD. WD induced an increase in cardiac fibrosis that was accompanied by increases in expression of TGF-β1 and phosphorylated-Smad2/3, whereas (p) of Smad7 was decreased (Figure 2 ; Figure S1 in the online-only Data Supplement). Importantly, ECMR −/− also attenuated the WD-induced increases in cardiac immunostaining for collagen 1, connective TGF, and fibronectin, as well as TGF-β1/Smad signaling, in conjunction with prevention of interstitial fibrosis (Figure 2 ; Figure S1 ).
ECMR −/− Prevented WD-Induced Myocardial Oxidative Stress, Adaptive Proinflammatory Cytokines, and Macrophage M1/M2 Polarization
In wild-type mice, WD promoted cardiac oxidant stress as indicated by increases in 3-nitrotyrosine immunostaining. This was associated with increases in cardiac tissue expression of the proinflammatory cytokines monocyte chemoattractant protein-1, interleukin (IL) 1, and IL17, as well as expression of the M1 macrophage markers, CD86 and CD11b (Figure 3) . ECMR −/− mice significantly prevented WD-induced increases in proinflammatory cytokines, such as IL17 and CD11b. Furthermore, WD-fed ECMR −/− mice also displayed increased 
ECMR −/− Prevents Abnormal Cardiac Insulin Metabolic Signaling
To investigate the roles of S6 kinase (S6K) in the phosphorylation of pSer-IRS-1 and p85-PI3K, S6K and IRS-1 were immunoprecipitated and then pSer-IRS-1 and p85-PI3K were immunoblotted, respectively. We have previously shown that WD feeding leads to increased serine/reduced tyrosine pIRS-1, less downstream PI-3K/Akt/eNOS activation in cardiovascular tissues. 32 WD feeding induced abnormal upregulation of S6K signaling ( Figure 4A and 4B) and this occurred in concert with upregulation of phosphorylated IRS-1 ( Figure 4C ) and downregulation of PI3-K/phosphorylated Akt/phosphorylated eNOS signaling ( Figure 4D-4F) . The absence of ECMR prevented the development of WD-induced impairments in upstream and downstream pathways associated with insulin signaling (Figure 4) . 
Discussion
In this study, we observed that consumption of a WD for 16 weeks in female mice resulted in cardiac diastolic relaxation impairment. This diastolic dysfunction was associated with the presence of LV fibrosis, cardiomyocyte stiffness, and increased inflammation, oxidative stress, and fibrosis promoting signaling pathways. Concomitantly, cardiac insulin metabolic signaling was reduced and associated with diminution of eNOS phosphorylation/activation. The diastolic dysfunction, as well as the structural and biochemical changes associated with WD consumption, was absent in a specific ECMR −/− female mouse model. We had previously observed that a WD was associated with impaired diastolic relaxation at an earlier age in female mice (8 weeks) than in male mice. 4 Low-dose spironolactone, a global MR inhibitor, prevents the development of myocardial and vascular stiffness and diastolic dysfunction in females consuming a WD. 37 , 38 Here, we uniquely demonstrate that EC-specific deletion of the MR prevents the development of WD-associated impairment in diastolic relaxation in conjunction with reductions in profibrotic signaling pathways, inflammation, and improvement in cardiac insulin metabolic signaling female mice. In particular, WD promotion of cardiac interstitial fibrosis, oxidative stress, M1/2 macrophage polarization, and hypertrophy was also largely absent in ECMR −/− female mice. The failure to develop abnormalities in cardiac structure and function in ECMR −/− female mice occurred without abrogation of WD-induced alterations in body weight, fat mass and systemic insulin resistance, or changes in mean arterial pressure. This suggests that WD-induced structural and functional changes in cardiovascular tissues occur before overt development of hypertension as has been previously reported for conduit vascular stiffness. 39 To the best of our knowledge, this is the first study examining the impact of cellspecific deletion of the MR in females and the first endeavor to investigate the impact of endothelial-specific MR deletion on cardiac structure and function. Taken together, these findings support the notion that increased ECMR signaling associated with consumption of a WD plays a key role in the development of cardiac fibrosis and diastolic dysfunction.
We previously reported that young female C57BL6 mice exhibit higher serum levels of aldosterone compared with males (≈50% higher in females versus males), but WD had no effect on aldosterone levels in males or females. 4 Therefore, we speculate that the interaction of higher aldosterone levels in females and consumption of a WD high in fat, fructose, and sucrose may act synergistically to promote the observed increases in oxidative stress, inflammation, fibrosis, and diastolic dysfunction. Indeed, data from our and other laboratories have suggested that consumption of a WD by excess intake of fat and carbohydrates can activate the reninangiotensin-aldosterone system and result in cardiovascular dysfunction and impaired cardiovascular tissue insulin metabolic signaling. 38, 40 Activation of the profibrotic TGF-β1/Smad signaling pathway in association with the observed increase in myocardial interstitial fibrosis in WD-fed mice are likely the major factors contributing to diastolic dysfunction in our study, and this was largely prevented in the ECMR −/− mice. 38 To this point, TGF-β1 is a powerful initiator for the synthesis of collagens and other major extracellular matrix components in cardiovascular tissue. 41 TGF-β1 regulates fibroblast proliferation and extracellular matrix production, particularly of collagen and fibronectin, while reducing degradation of these components through Smad2/3.
42 Smad7 is also a ligand of TGF-β1 but it is a TGF-β1 antagonist and interacts with activated TGF-β1, thereby blocking the association, phosphorylation, and activation of Smad2/3. 43 Connective TGF and collagen 1 are profibrotic factors that are involved in promoting cardiac stiffness 4, 12 and are increased through TGF-β1/ Smad signaling. 4, 12, 42, 44, 45 The WD-induced increase in expression of these matrix/fibrotic proteins was prevented/abrogated by ECMR deletion. To our knowledge, our report is the first to link ECMR to cardiac stiffness.
The results of this study are consistent with data from a recent study showing a role of the ECMR in modulating myocardial profibrotic and proinflammatory responses to DOCA/ salt. 12 As in that study, we also observed reduced macrophage polarization in ECMR null mice. To this point, monocyte chemoattractant protein-1-directed macrophage recruitment plays a direct role in MR-dependent DOCA/salt-induced cardiac fibrosis and hypertension. 11 However, in the previous study, the precise role of ECMR −/− was confounded by the use of a Tie 2/Tek promoter to drive the expression of Cre recombinase. 12, 13 In this regard, the Tie2 promoter has been shown to affect all myeloid cells, including macrophages. 13, 24 This is an important distinction as the macrophage MR has been reported to promote inflammatory macrophage polarization and associated fibrosis, hypertrophy, and remodeling. 8 However, the beneficial cardiac effects observed with ECMR KO in this study were similar to that observed previously using the Tie2 promoter in male mice subjected to mineralocorticoid/salt treatment.
12 Thus, the current study is the first to demonstrate that selective ECMR KO 33 prevents fibrosis and remodeling and associated diastolic dysfunction in the translational setting of a WD.
The results of this investigation further suggest that consumption of a WD plays a role in the generation of oxygen-free radicals and ECMR −/− prevents oxidative stress (myocardial 3-nitrotyrosine levels) and related fibrosis. This observation highlights the potential role of ECMR in promotion of reactive oxygen species-mediated fibrogenesis. Furthermore, oxygen-free radicals likely induced and increased proinflammatory cytokines, including monocyte chemoattractant protein-1, IL1, and IL17 in female mice fed a WD. These data are consistent with a model in which EC injury because of active MR signaling promotes immune cell activation, including T lymphocytes migration to secondary lymphoid organs, as well as recruitment and activation of macrophages into the cardiac tissues. 46 Indeed, MR activation in immune cells has been reported to promote differentiation of naive CD4 T cells into Th1 and Th17 proinflammatory phenotypes and downregulation of regulatory T lymphocytes, which are involved in the pathogenesis of cardiac fibrosis and diastolic dysfunction. 46, 47 Moreover, consumption of a WD promoted a proinflammatory macrophage M1/M2 polarization that was prevented in ECMR −/− . This finding is consistent with previous results showing that the loss of MR in macrophage-MR KO mice resulted in reduction in M1 phenotype and mRNA levels for markers of cardiovascular inflammation. 10, 47 Macrophage polarization favoring an enhanced M1 proinflammatory response and suppressing an M2 anti-inflammatory response occurs in diet-induced cardiac disease. The proinflammatory M1 macrophages secrete inflammatory cytokines to cause insulin resistance and cardiac dysfunction. 48 In contrast, M2 macrophages secrete IL10, which attenuates cardiomyocyte hypertrophy and cardiac fibrosis. 48 Thus, activation of ECMR resulting in an increased adaptive inflammation response and macrophage M1/M2 polarization could contribute to cardiac fibrosis, stiffness, and diastolic dysfunction that is characteristic of longstanding heart failure in females with obesity, the metabolic syndrome, and type 2 diabetes mellitus.
The results of this investigation further suggest that a WD promotes cardiac hypertrophy, driven by ECMR-mediated reductions in insulin metabolic signaling and associated activation of growth promoting S6K-1 and ERK signaling. Indeed, both S6K-1 and ERK have been implicated as mediators of cardiac hypertrophy in both cell culture and in genetically modified mouse models. 32, 49 These kinases become activated in cardiac cardiomyocytes in response to many stimuli, such as inflammation, oxidative stress, reductions in bioavailable NO, and aldosterone. 50, 51 The role of ECMR signaling in modulating these growth promoting kinases is underscored by our findings that ECMR −/− prevented WD-induced S6K-1 and ERK activation and cardiac hypertrophy. Reductions in eNOS activity and increased reactive oxygen species destruction of NO leading to reduced bioavailable NO may also have contributed to cardiomyocyte hypertrophy in WD-fed female mice.
12,52
Perspectives
The results of this investigation suggest that signaling through ECMR plays a critical role in development of WD-induced cardiac diastolic dysfunction in females. Indeed, ECMR deletion prevented the cardiac inflammation, oxidative stress, maladaptive immune responses, and fibrosis associated with consumption of a high fat/sucrose/high fructose corn syrup diet. One limitation of this study is that we did not compare these pathophysiological changes in male and female ECMR KO mice, although the cardiac impact of ECMR KO is similar to that seen previously in males subjected to a different treatment paradigm. Thus, future more long-term studies need to done in male ECMR KO mice subjected to WD feeding. Nevertheless, this investigation has uncovered potentially important mechanism by which overweight and insulin-resistant females are at especially high risk of developing diastolic heart failure. Finally, targeting the ECMR may be an effective strategy to limit heart failure development and progression in overweigh/obesity females that are at substantial risk of cardiovascular events.
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What Is New?
• These data indicate that consumption of a Western diet, high in fat and refined sugars promotes fibrosis, stiffness, and impaired cardiac diastolic relaxation in female mice. Development of this cardiac phenotype can be prevented by selective deletion of the endothelial cell mineralocorticoid receptor.
What Is Relevant?
• Metabolic cardiomyopathy characterized by selective impairment of diastolic relaxation often occurs in young overweight and insulin-resistant females. Using a very translational model of insulin resistance, female mice fed a Western diet, this research show that diet-induced activation of the endothelial cell mineralocorticoid receptor is critical for development of impaired diastolic relaxation in females.
Summary
The results of this investigation suggest that enhanced endothelial cell mineralocorticoid receptor activation plays an integral role in development of cardiac fibrosis and diastolic dysfunction that is promoted by consumption of a Western diet in females. 
